Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Psychiatr Pol ; 52(2): 323-343, 2018 Apr 30.
Artículo en Inglés, Polaco | MEDLINE | ID: mdl-29975370

RESUMEN

The position of selective mutism disorder - SM - has been modified in the last edition of the classification of mental disorders DSM-5. It was removed from "Disorders of childhood and adolescence" and placed in "Anxiety disorders". This caused two important changes in the interpretation of the symptoms of selective mutism. It highlighted anxious etiology of the disorder and also open the possibility to diagnose selective mutism in adults as a special category of anxiety disorders. The aim of this study was to present three different cases concerning the diagnostic difficulties of selective mutism (the child, the teenager and the persons who became adult during our observation) regarding current views on SM. In this study we presented the current view on the etiology, course and available therapies for selective mutism. Owing to updating the clinical knowledge about SM and describing three cases, we highlighted the controversies around the diagnosis and treatment of this disorder. Selective mutism might be a preliminary diagnosis, often leading to the diagnosis of other disorders of diverse etiology and course. Among the psychiatric aspects of the disorder, the 'anxiety component' of SM is crucial. In individuals with selective mutism, developmental disorders, social cognition and neurocognition deficits or dysfunctions of auditory processing often coexist. The severity and the type of comorbidities may determine the future course of the illness and the final effects of the therapy.


Asunto(s)
Mutismo/clasificación , Mutismo/diagnóstico , Índice de Severidad de la Enfermedad , Adolescente , Adulto , Trastornos de Ansiedad/clasificación , Trastornos de Ansiedad/diagnóstico , Niño , Trastornos de la Conducta Infantil/clasificación , Trastornos de la Conducta Infantil/diagnóstico , Femenino , Humanos , Masculino , Mutismo/complicaciones , Trastornos Fóbicos/clasificación , Trastornos Fóbicos/diagnóstico , Medición de Riesgo
2.
Int J Psychiatry Clin Pract ; 22(1): 70-76, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28826267

RESUMEN

OBJECTIVE: Numerous studies confirm efficacy of psychiatric treatment as well as psychiatric placebo. The aim of the current study was the assessment of improvement rate and factors associated with treatment response in naturalistic group of adolescent inpatients. METHODS: Eighty two consecutive adolescent inpatients were recruited. Each patient at the admission and discharge was assessed with brief psychiatric rating scale (BPRS), eating attitude test (EAT-26), clinical global impression scale (CGI-S) and children global assessment scale (CGAS). Individual and family history was assessed by semi-structured interview. Patients, who improved in at least two interviewer-based scales (IMP, n = 67) were compared to the rest (N-IMP, n = 15). For statistical analysis STATISTICA package was used. RESULTS: The main difference between groups was ICD-10 diagnosis distribution: in the IMP group more anxiety-related disorders (F4), in the N-IMP group more personality disorders (F6). Other differences include history of paediatric hospitalisations and surgery (more in the N-IMP group). Most of the analysed factors did not differ between groups. CONCLUSIONS: The inpatient treatment seems to be most effective in severe mental states and in anxiety-related disorders and least effective in personality disorders. Due to limited inpatient treatment efficacy we believe outpatients services are crucial in adolescent psychiatry.


Asunto(s)
Hospitalización , Trastornos Mentales/terapia , Evaluación de Resultado en la Atención de Salud , Escalas de Valoración Psiquiátrica , Adolescente , Trastornos de Ansiedad/terapia , Femenino , Humanos , Pacientes Internos , Clasificación Internacional de Enfermedades , Masculino , Trastornos de la Personalidad/terapia , Pronóstico
3.
Psychiatr Pol ; 50(2): 357-73, 2016.
Artículo en Inglés, Polaco | MEDLINE | ID: mdl-27288681

RESUMEN

OBJECTIVES: In Poland, no guidelines concerning the mode of delivery in patients with psychiatric disorders have so far been developed. The most common psychiatric diagnosis discussed in the Polish literature in the context of the indications for the elective caesarean section is tokophobia. It was confirmed in recent studies that intense fear of childbirth, requiring medical interventions is an important predictor of postpartum depression. Other studies have shown that emergency delivery causes long lasting posttraumatic stress disorder symptoms. The aim of this paper is to discuss the different mental disorders, which may determine psychiatric indications for elective CS. METHODS: A literature review and analysis of two cases. Review of the literature was made via MEDLINE and based on such a keywords as: mental health, mode of delivery, caesarean section, psychiatric indications for CS. In the analysis, papers based on population studies and essential because of the potential clinical decisions concerning psychiatric indications for CS were taken into account first. RESULTS: Psychiatric indications for the preferred type of delivery are determined individually. They are mainly based on the ability of the psychiatric patient to cooperate with obstetric staff during vaginal delivery. The second area of psychiatric indications is a strong fear of labour that results in the need for psychiatric consultation in the last trimester of pregnancy or the perinatal period. CONCLUSIONS: Antenatal care of women with mental disorders requires close cooperation between the obstetricians and psychiatrists specialised in the mental disorders due to somatic state. Such cooperation should lead to preventing both obstetric and psychiatric complications during the pregnancy and labour in women experiencing symptoms of mental disorders.


Asunto(s)
Cesárea/psicología , Procedimientos Quirúrgicos Electivos/psicología , Complicaciones del Trabajo de Parto/psicología , Parto/psicología , Prioridad del Paciente/psicología , Trastornos por Estrés Postraumático/psicología , Parto Obstétrico/psicología , Femenino , Humanos , Embarazo , Factores de Riesgo , Esfuerzo de Parto , Adulto Joven
4.
Psychiatr Pol ; 49(1): 81-93, 2015.
Artículo en Polaco | MEDLINE | ID: mdl-25844412

RESUMEN

Quetiapine is an atypical antipsychotic agent, frequently used in psychiatry, often for symptomatic treatment against a number of mental disorders differing from the registration indications. One of the use is to soothe the clinical conditions caused by the use of various psychoactive substances. The paper presents and discusses the reports of quetiapine misuse, abuse, and even mental addiction, as well as symptoms similar to the so-called discontinuation syndrome, often mixed with withdrawal syndrome occurring in the course of addiction. Most reports concern males, and especially those with a history of other psychoactive substance abuse, and personality disorders, often in conflict with the law. Therefore, clinicians should be cautious when prescribing quetiapine to such patients. The article discusses potential mechanisms responsible for quetiapine abuse. This is probably related to its sedative and anxiolytic activity which results in the frequent use with stimulants. Also, high affinity for the H1 receptor, as antihistamines agents causes rewarding action.


Asunto(s)
Antipsicóticos/efectos adversos , Dibenzotiazepinas/efectos adversos , Mal Uso de Medicamentos de Venta con Receta/estadística & datos numéricos , Síndrome de Abstinencia a Sustancias/etiología , Trastornos Relacionados con Sustancias/etiología , Antipsicóticos/administración & dosificación , Trastorno Bipolar/tratamiento farmacológico , Dibenzotiazepinas/administración & dosificación , Humanos , Fumarato de Quetiapina , Esquizofrenia/tratamiento farmacológico , Trastornos Relacionados con Sustancias/diagnóstico
5.
Psychiatr Pol ; 48(5): 901-16, 2014.
Artículo en Polaco | MEDLINE | ID: mdl-25639012

RESUMEN

AIM: A few cases of psychosis induced by clomiphene citrate have been described so far. However, data on the prevalence of psychotic symptoms among women treated for infertility are inconclusive. Still a little is known about possible psychiatric complications of medications used in assisted reproduction techniques (ART). We present a case of a patient who developed transient psychotic symptoms in the course of the in vitro fertilization procedures. To our kiiowledge, this is the first case of 'mid-stimulation psychosis', which has been observed during ART using clomiphene.citrate and bromocriptine. The aim of this study is to describe the determinants ofpharmacotherapy undertaken in ART,.which can result in the development of psychotic symptoms. METHODS: The Case presentation. CONCLUSIONS: The use of clomiphene citrate for ovulation induction in combination with bromocriptine used for chronic hyperprolactinemia is a likely mechanism that might have triggered psychotic symptoms in the case presented. However, combination therapy with clomiphen citrate and.bromocriptine may be the pharmacological model of hyper-dopaminergia followed by chaotic changes in serum estrogen levels and might lead to an increased sensitivity of dopamine receptors. The above therapeutic schema may increase susceptibility to the development of psychotic symptoms in treated women. This impact should be considered in the case of any psychotic complications in patients undergoing assisted reproduction techniques


Asunto(s)
Bromocriptina/efectos adversos , Clomifeno/efectos adversos , Fármacos para la Fertilidad Femenina/efectos adversos , Infertilidad Femenina/tratamiento farmacológico , Psicosis Inducidas por Sustancias/etiología , Adulto , Bromocriptina/administración & dosificación , Clomifeno/administración & dosificación , Relación Dosis-Respuesta a Droga , Femenino , Fármacos para la Fertilidad Femenina/administración & dosificación , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA